Has Wesley Clark, MD received payments from drug or device companies?

Yes. Drug and device makers reported $153,179 in general payments to Wesley Clark, MD across 324 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wesley Clark, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wesley Clark, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wesley Clark, MD

Adult Reconstructive Orthopaedic Surgery · New Orleans, LANPI 1225220551

Payments from drug & device makers

$153,179in general payments, 2019–2025

Across 324 payments — averaging $472.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medacta USA, Inc.$127K
Lima USA, Inc.$15K
Shalby Advanced Technologies, Inc.$6K
Globus Medical$1K
Stryker$892
Davol Inc.$410
plus $3K from 39 others

$27,145in research payments, 2019–2025

Across 16 payments — averaging $1696.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medacta USA, Inc.$27K

What the payments were for

Consulting fees$114,15975%
Travel & lodging$28,30218%
Food & beverage$10,7177%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medacta USA, Inc.	149	$127,407
Lima USA, Inc.	20	$14,708
Shalby Advanced Technologies, Inc.	15	$5,896
Globus Medical	18	$1,248
Stryker	27	$892
Davol Inc.	6	$410
Amgen(2 entities)	12	$290
Johnson & Johnson(2 entities)	4	$268
Medtronic(2 entities)	5	$209
Heron Therapeutics, Inc.	4	$194
Medical Device Business Services, Inc.	2	$151
Linkbio Corp	1	$140
UOC USA Inc	1	$120
Ferring Pharmaceuticals Inc.	8	$119
Nextstep Arthropedix, LLC	1	$106
Pacira Therapeutics, Inc.	6	$100
Radius Health, Inc.	5	$93
Fidia Pharma USA Inc.	2	$78
Biocomposites Inc	2	$75
Avanos Medical	2	$73
Bioventus LLC	3	$71
Acera Surgical, Inc.	1	$39
Organogenesis Inc.	1	$33
BREG, Inc	2	$32
Pacira Pharmaceuticals Incorporated	2	$31
Boston Scientific	1	$28
Pfizer	2	$26
Si-bone, Inc.	1	$26
Kowa Pharmaceuticals America, Inc.	2	$25
Vericel Corporation	1	$24
FX Shoulder Solutions, Inc	1	$23
Innovation Technologies Inc	1	$23
Abbott	1	$21
Orthogenrx Inc.	1	$21
Saluda Medical Americas, Inc.	3	$21
Sanara Medtech Inc.	1	$20
Sanofi-aventis U.S. LLC	1	$19
Zimmer Biomet	1	$18
Polynovo North America LLC	1	$16
Smith+Nephew	1	$16
Advanced Oxygen Therapy Inc.	1	$16
Vertex	1	$15
Zyla Life Sciences, Inc.	1	$14
KCI USA, Inc.	1	$13
Heraeus Medical, LLC.	2	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Louisianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$177,001

Medicare patients

310

Services billed

7,619

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	440	$5,150
Gabapentin	582	$4,108
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	224	$2,638
Ondansetron OdtOndansetron	138	$1,906
Diclofenac Sodium	133	$1,630
Tizanidine Hcl	277	$1,151
Mupirocin	138	$1,016
Tramadol Hcl	279	$1,015
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	94	$800
Meloxicam	225	$540
Ibuprofen	46	$401
Cyclobenzaprine Hcl	61	$224
Acetaminophen-CodeineAcetaminophen With Codeine	18	$130
Methylprednisolone	19	$112
Cephalexin	11	$95

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in New Orleans

Eric GreberThibodaux$211K
Paul BuzhardtLafayette$101K
Fernando NussenbaumMandeville$18K
Alex BetechBaton Rouge$15K
Benjamin FeibelShreveport$12K
Robert DuarteLake Charles$2K

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →